UNSPSC 51286903: Drazidox

This classification denotes an antibiotic with the molecular formula C10H10N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W193003XW5, chemically known as 3-methyl-2-quinoxalinecarboxylic acid hydrazide 1,4-dioxide. but more generally known as drazidox, which bears US NIH Compound Identifier 208897. European Medicines Agency schedules Drazidox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06398MIG. The term DRAZIDOX is an International Non-Proprietary Name.

DRAZIDOX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: CC1=C(N(C2=CC=CC=C2N1O)O)C(=O)N=N.

UNSPSC 51286903 Drazidox, a Commodity code, describes pharmaceutical products and related medical supplies that state and local governments procure for emergency response, public health, and pharmacy benefit programs. Recent solicitations show state and local buyers acquiring naloxone and drug deactivation systems for community health initiatives, generic pharmaceuticals and over-the-counter products through cooperative purchasing alliances, medical and first aid supplies for fire department rescue divisions, and exploring direct-to-manufacturer prescription fulfillment models to improve cost management and supply chain efficiency. The issuing bodies span county health departments, state health and human services commissions, municipal fire departments, and multistate cooperative purchasing organizations, reflecting a diverse base of health care and emergency-response customers procuring pharmaceuticals and related medical supplies at scale.

Recent activity appears concentrated in Florida and Minnesota, with Texas exploring emerging pharmacy benefit models. Seminole County, Florida issued an IFB (IFB60459723LAS) in June 2026 to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The City of Tampa's Purchasing Department solicited sealed bids (26P00145) in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000.00 and a sheltered-market small local business enterprise set-aside and 5 percent bid discount. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued an RFP (S1070000015802) due March 26, 2026 to establish multiple-award contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon. The Texas Health and Human Services Commission posted an RFI (HHS0017013) in April 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements, signaling state interest in alternative supply chain models.